NasdaqGS - Nasdaq Real Time Price USD
Repare Therapeutics Inc. (RPTX)
At close: October 18 at 4:00 PM EDT
After hours: October 18 at 4:06 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-79,608.0000
-127,158.0000
322.0000
-85,796.0000
-6,084.0000
--
Investing Cash Flow
43,179.0000
78,041.0000
-175,778.0000
-1,676.0000
-9,763.0000
--
Financing Cash Flow
764.0000
842.0000
880.0000
95,557.0000
247,842.0000
--
End Cash Position
79,879.0000
111,268.0000
159,521.0000
334,427.0000
326,396.0000
--
Income Tax Paid Supplemental Data
--
4,945.0000
10,810.0000
25.0000
156.0000
--
Capital Expenditure
--
-1,938.0000
-602.0000
-1,690.0000
-2,237.0000
--
Issuance of Capital Stock
--
--
--
94,288.0000
232,043.0000
103,243.0000
Free Cash Flow
-80,006.0000
-129,096.0000
-280.0000
-87,486.0000
-8,321.0000
--
12/31/2019 - 6/19/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SYRE Spyre Therapeutics, Inc.
32.76
0.00%
IDYA IDEAYA Biosciences, Inc.
30.54
-0.49%
STOK Stoke Therapeutics, Inc.
13.00
-2.03%
BCYC Bicycle Therapeutics plc
27.03
+1.08%
VIGL Vigil Neuroscience, Inc.
3.9600
-0.75%
CYTK Cytokinetics, Incorporated
54.97
+0.81%
IMTX Immatics N.V.
9.88
+3.46%
URGN UroGen Pharma Ltd.
12.73
-0.86%
KYMR Kymera Therapeutics, Inc.
46.41
+0.35%
RGNX REGENXBIO Inc.
11.10
+4.72%